Similar articles for PMID: 17893975

Year	Number of Results
1996	1
2003	3
2004	3
2005	9
2006	7
2007	7
2008	7
2009	4
2010	5
2011	2
2012	9
2013	3
2014	7
2015	7
2016	6
2017	8
2018	5
2019	2
2020	2
2021	1
2022	2
2023	2
2024	0

1

Annexin A5 as a novel player in prevention of atherothrombosis in SLE and in the general population.

Cederholm A, Frostegård J. Cederholm A, et al. Ann N Y Acad Sci. 2007 Jun;1108:96-103. doi: 10.1196/annals.1422.011. Ann N Y Acad Sci. 2007. PMID: 17893975 Review.

2

Annexin A5 multitasking: a potentially novel antiatherothrombotic agent?

Cederholm A, Frostegård J. Cederholm A, et al. Drug News Perspect. 2007 Jun;20(5):321-6. doi: 10.1358/dnp.2007.20.5.1120220. Drug News Perspect. 2007. PMID: 17878960 Free article. Review.

3

Annexin A5 in cardiovascular disease and systemic lupus erythematosus.

Cederholm A, Frostegård J. Cederholm A, et al. Immunobiology. 2005;210(10):761-8. doi: 10.1016/j.imbio.2005.10.007. Epub 2005 Oct 20. Immunobiology. 2005. PMID: 16325495 Review.

4

Systemic lupus erythematosus and cardiovascular disease.

Frostegård J. Frostegård J. Lupus. 2008 May;17(5):364-7. doi: 10.1177/0961203308089988. Lupus. 2008. PMID: 18490408 Review.

5

Decreased binding of annexin v to endothelial cells: a potential mechanism in atherothrombosis of patients with systemic lupus erythematosus.

Cederholm A, Svenungsson E, Jensen-Urstad K, Trollmo C, Ulfgren AK, Swedenborg J, Fei GZ, Frostegård J. Cederholm A, et al. Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):198-203. doi: 10.1161/01.ATV.0000150415.18759.36. Epub 2004 Nov 11. Arterioscler Thromb Vasc Biol. 2005. PMID: 15539620

6

Effects of anti-cardiolipin antibodies and IVIg on annexin A5 binding to endothelial cells: implications for cardiovascular disease.

Frostegård AG, Su J, von Landenberg P, Frostegård J. Frostegård AG, et al. Scand J Rheumatol. 2010;39(1):77-83. doi: 10.3109/03009740903124432. Scand J Rheumatol. 2010. PMID: 20132075

7

SLE, atherosclerosis and cardiovascular disease.

Frostegård J. Frostegård J. J Intern Med. 2005 Jun;257(6):485-95. doi: 10.1111/j.1365-2796.2005.01502.x. J Intern Med. 2005. PMID: 15910552 Free article. Review.

8

Transcellular distribution heterogeneity of Annexin A5 represents a protective response to lupus-related thrombophilia: a pilot Proteomics-based study.

Zhou D, Luo N, Wu Q, You Y, Zhai Z, Mou Z, Wu Y, Hao F. Zhou D, et al. Biochem Biophys Res Commun. 2012 Apr 6;420(2):357-63. doi: 10.1016/j.bbrc.2012.02.162. Epub 2012 Mar 8. Biochem Biophys Res Commun. 2012. PMID: 22425772

9

Systemic lupus erythematosus and cardiovascular disease.

Frostegård J. Frostegård J. J Intern Med. 2023 Jan;293(1):48-62. doi: 10.1111/joim.13557. Epub 2022 Aug 18. J Intern Med. 2023. PMID: 35982610 Free PMC article. Review.

10

Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.

Gustafsson JT, Herlitz Lindberg M, Gunnarsson I, Pettersson S, Elvin K, Öhrvik J, Larsson A, Jensen-Urstad K, Svenungsson E. Gustafsson JT, et al. PLoS One. 2017 Apr 17;12(4):e0174572. doi: 10.1371/journal.pone.0174572. eCollection 2017. PLoS One. 2017. PMID: 28414714 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

84 results

Results by year